Malignant Peritoneal Neoplasm Completed Phase 2 Trials for Alisertib (DB05220)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed2 IdentifierTitlePurposeDrugs
NCT01091428Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast CancerTreatment